BTK Inhibitors for Mantle Cell Lymphoma

BTK Inhibitors for Mantle Cell Lymphoma Treatment Are Showing Promising Results

Lymphoma expert Dr. Peter Martin explains why BTK Inhibitors may be used as frontline therapy. "Not everybody with mantle cell lymphoma needs or benefits from chemotherapy."

"BTK Inhibitors have revolutionized the way we care with patients with mantle cell lymphoma," explains Dr. Peter Martin, Assistant Professor of Medicine in the Division of Hematology/Oncology at Weill Cornell Medical College and a member of the Center for Lymphoma and Myeloma. Dr. Martin and Patient Power co-founder Andrew Schorr discuss how BTK Inhibitors are currently being used as a mantle cell lymphoma treatment and the studies that are exploring how BTK Inhibitors work in combination with other drug therapies.

© 2024 HealthCentral LLC. All rights reserved.

More on Mantle Cell Lymphoma